GLP-1s for endometriosis: what we actually know

The short, honest answer

I want to be straight with you from the first line, because much of the internet isn't on this topic: there is still no good evidence that GLP-1 medications treat endometriosis. They aren't approved for it, there are no large trials showing they shrink lesions or ease endometriosis pain, and any claim otherwise is running ahead of the science. What does exist is a small, early, mostly indirect research trail, and I'd rather explain it to you honestly than sell you a hope that isn't founded yet.

Why people ask the question at all

Endometriosis is a chronic condition in which tissue similar to the lining of the uterus grows outside it, often causing pain and affecting fertility. It's increasingly understood as an inflammatory condition and, in some women, one tied to metabolism¹. Because GLP-1 medications calm some inflammatory and metabolic pathways and are being explored across gynecology³, it's a reasonable question to ask. But reasonable to ask isn't the same as answered.

The nuance almost nobody tells you: weight and endometriosis aren't a simple story

With PCOS, the logic is clean: weight and insulin resistance drive a lot of it, so losing weight helps. Endometriosis is different, and this surprises people. In a meta-analysis of body mass index and endometriosis, a higher BMI was actually associated with a lower risk of endometriosis, not a higher one². So you can't simply borrow the "a GLP-1 helps you lose weight, therefore it helps the condition" argument out of the PCOS playbook. The relationship between metabolic health and endometriosis is real but tangled — some studies do link endometriosis with features of metabolic syndrome⁵ — and it doesn't map cleanly onto weight loss.

What the early biology hints at

Here's the genuinely interesting and genuinely preliminary part. A study measuring hormones in the pelvic (peritoneal) fluid of women with endometriosis found that GLP-1 levels were lower there compared with women without the condition, along with other changes in inflammatory and metabolic markers⁴. That's a fascinating clue that GLP-1 signaling is altered in endometriosis, but it's a small observational finding about the body's own GLP-1 — not evidence that a GLP-1 medication changes the disease. Please hold it loosely.

What the people reviewing the evidence say out loud

The most current gynecology reviews put it plainly: research into GLP-1 medications for conditions beyond PCOS — including infertility and endometrial hyperplasia — is ongoing, and more studies are needed before any recommendation can be made³. A broader review of medical therapy to support metabolic health and fertility in women of reproductive age echoes that GLP-1 medications are a promising area still being defined, not a settled treatment⁶. In other words: interesting, unproven, stay tuned.

So what can a GLP-1 actually do right now?

What these medications genuinely have proven is helping with weight and blood sugar⁷. If you have endometriosis and a separate reason a clinician would consider a GLP-1 — like weight management or type 2 diabetes — that's a real, evidence-based use, and endometriosis doesn't automatically rule it out. But that's treating the other condition, not endometriosis itself. And as always, these medications are not used during pregnancy or while trying to conceive, which matters a great deal in a condition so tied to fertility⁸.

A calm next step

If you live with endometriosis, the people who should be guiding this are a gynecologist who knows your case and, if weight or metabolic health is also on the table, a clinician who can weigh a GLP-1 for that reason. If fertility is part of your story, GLP-1s and fertility is worth reading next. You deserve information that respects how little is settled here. — Camila